$FOR
Forestar Group Inc. Stock $for

$for Overview Financials Valuation SEC Filings Company Website

2020 Form 10-K Financial Statement

#000140658720000087 Filed on November 19, 2020

Income Statement

Concept	2020	2019 Q3	2019 Q2
Revenue	$931.8M	$236.3M	$88.20M
YoY Change	117.56%	633.85%	273.73%
Cost Of Revenue	$813.7M	$213.1M	$75.30M
YoY Change	124.35%	810.68%	653.0%
Gross Profit	$118.1M	$23.20M	$12.90M
YoY Change	80.03%	163.64%	-5.15%
Gross Profit Margin	12.67%	9.82%	14.63%
Selling, General & Admin	$45.70M	$9.100M	$7.900M
YoY Change	58.13%	102.22%	21.54%
% of Gross Profit	38.7%	39.22%	61.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.900M	$1.900M	$1.800M
YoY Change	-26.87%	46.15%	38.46%
% of Gross Profit	4.15%	8.19%	13.95%
Operating Expenses	$45.70M	$9.100M	$7.900M
YoY Change	58.13%	24.66%	21.54%
Operating Profit	$72.40M	$14.10M	$5.000M
YoY Change	97.28%	840.0%	-40.57%
Interest Expense	$0.00	$1.400M	$0.00
YoY Change		-68.18%	-100.0%
% of Operating Profit	0.0%	9.93%	0.0%
Other Income/Expense, Net
YoY Change
Pretax Income	$78.10M	$16.00M	$8.400M
YoY Change	70.9%	-45.95%	-19.23%
Income Tax	$16.40M	$3.400M	$1.500M
% Of Pretax Income	21.0%	21.25%	17.86%
Net Earnings	$60.80M	$12.70M	$6.900M
YoY Change	84.24%	-76.87%	-26.6%
Net Earnings / Revenue	6.53%	5.37%	7.82%
Basic Earnings Per Share	$1.26	$0.30	$0.16
Diluted Earnings Per Share	$1.26	$0.30	$0.16
COMMON SHARES
Basic Shares Outstanding	48.04M shares	41.96M shares	41.96M shares
Diluted Shares Outstanding	48.09M shares		42.01M shares

Balance Sheet

Concept	2020	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$394.3M	$382.8M	$223.0M
YoY Change	3.0%	20.08%	-39.37%
Cash & Equivalents	$394.3M	$382.8M	$223.2M
Short-Term Investments
Other Short-Term Assets	$4.900M	$3.400M	$4.000M
YoY Change	44.12%	9.68%	29.03%
Inventory
Prepaid Expenses
Receivables	$400.0K	$1.100M	$1.400M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$399.6M	$387.3M	$228.4M
YoY Change	3.18%	20.32%	-38.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.314B	$2.400M	$2.400M
YoY Change	27.45%	41.18%	33.93%
Goodwill
YoY Change
Intangibles		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Investments	$3.600M	$7.300M	$7.300M
YoY Change	-50.68%	-37.61%	-59.37%
Other Assets	$0.00	$17.40M	$21.20M
YoY Change	-100.0%	-59.53%	-50.35%
Total Long-Term Assets	$1.340B	$1.068B	$1.097B
YoY Change	25.45%	87.04%	149.35%
TOTAL ASSETS
Total Short-Term Assets	$399.6M	$387.3M	$228.4M
Total Long-Term Assets	$1.340B	$1.068B	$1.097B
Total Assets	$1.740B	$1.456B	$1.325B
YoY Change	19.52%	62.99%	63.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$29.20M	$16.80M	$18.80M
YoY Change	73.81%	112.66%	347.62%
Accrued Expenses	$73.30M	$65.00M	$45.20M
YoY Change	12.77%	80.56%	115.24%
Deferred Revenue		$2.500M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$201.3M	$171.7M	$148.8M
YoY Change	17.24%	84.03%	122.75%
LONG-TERM LIABILITIES
Long-Term Debt	$641.1M	$460.5M	$458.9M
YoY Change	39.22%	312.26%	315.29%
Other Long-Term Liabilities	$20.00M	$5.300M	$12.80M
YoY Change	277.36%	-60.74%	-3.76%
Total Long-Term Liabilities	$661.1M	$465.8M	$471.7M
YoY Change	41.93%	272.04%	281.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$201.3M	$171.7M	$148.8M
Total Long-Term Liabilities	$661.1M	$465.8M	$471.7M
Total Liabilities	$869.0M	$646.8M	$629.9M
YoY Change	34.23%	195.88%	230.36%
SHAREHOLDERS EQUITY
Retained Earnings		$158.1M	$145.4M
YoY Change		26.38%	106.97%
Common Stock		$650.2M	$549.3M
YoY Change		18.61%	0.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$870.9M	$808.3M	$694.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.740B	$1.456B	$1.325B
YoY Change	19.52%	62.99%	63.43%

Cashflow Statement

Concept	2020	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	$60.80M	$12.70M	$6.900M
YoY Change	84.24%	-76.87%	-26.6%
Depreciation, Depletion And Amortization	$4.900M	$1.900M	$1.800M
YoY Change	-26.87%	46.15%	38.46%
Cash From Operating Activities	-$168.4M	$58.90M	-$166.6M
YoY Change	-56.95%	-158.43%	144.28%
INVESTING ACTIVITIES
Capital Expenditures	$600.0K	$0.00	-$100.0K
YoY Change	-33.33%
Acquisitions
YoY Change
Other Investing Activities	$5.600M	$0.00	$0.00
YoY Change	5500.0%	-100.0%	-100.0%
Cash From Investing Activities	$5.000M	$0.00	-$100.0K
YoY Change	-725.0%	-100.0%	-133.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$174.9M	100.7M	307.8M
YoY Change	-60.23%	388.83%	-44071.43%
NET CHANGE
Cash From Operating Activities	-$168.4M	58.90M	-166.6M
Cash From Investing Activities	$5.000M	0.000	-100.0K
Cash From Financing Activities	$174.9M	100.7M	307.8M
Net Change In Cash	$11.50M	159.6M	141.1M
YoY Change	-75.94%	-417.93%	-305.69%
FREE CASH FLOW
Cash From Operating Activities	-$168.4M	$58.90M	-$166.6M
Capital Expenditures	$600.0K	$0.00	-$100.0K
Free Cash Flow	-$169.0M	$58.90M	-$166.5M
YoY Change	-56.9%	-158.43%	144.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	City Area Code CityAreaCode	817
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001406587
CY2020Q3	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2019Q3	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-33662
CY2020	dei	Entity Registrant Name EntityRegistrantName	Forestar Group Inc.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1336998
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	2221 E. Lamar Blvd.
CY2020	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 790
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Arlington
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	76006
CY2020	dei	Local Phone Number LocalPhoneNumber	769-1860
CY2020	dei	Security12b Title Security12bTitle	Common Stock, par value $1.00 per share
CY2020	dei	Trading Symbol TradingSymbol	FOR
CY2020	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Public Float EntityPublicFloat	190000000	USD
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48070347	shares
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	394300000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	382800000	USD
CY2020Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1309700000	USD
CY2019Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1028900000	USD
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	3600000	USD
CY2019Q3	us-gaap	Equity Method Investments EquityMethodInvestments	7300000	USD
CY2020Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	6300000	USD
CY2019Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	3200000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1100000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2400000	USD
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2019Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	17400000	USD
CY2020Q3	us-gaap	Other Assets OtherAssets	24900000	USD
CY2019Q3	us-gaap	Other Assets OtherAssets	13700000	USD
CY2020Q3	us-gaap	Assets Assets	1739900000	USD
CY2019Q3	us-gaap	Assets Assets	1455700000	USD
CY2020Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	29200000	USD
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	98300000	USD
CY2019Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	16800000	USD
CY2019Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	89900000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5700000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2020Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	93800000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	79600000	USD
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	641100000	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	460500000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	868100000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	646800000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48061921	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47997366	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	48100000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	48000000.0	USD
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	603900000	USD
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	602200000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	218900000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	158100000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	870900000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	808300000	USD
CY2020Q3	us-gaap	Minority Interest MinorityInterest	900000	USD
CY2019Q3	us-gaap	Minority Interest MinorityInterest	600000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	871800000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	808900000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1739900000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1455700000	USD
CY2020	us-gaap	Revenues Revenues	931800000	USD
CY2019	us-gaap	Revenues Revenues	428300000	USD
	us-gaap	Revenues Revenues	78300000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	813700000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	362700000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	49500000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	45700000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28900000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19400000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	700000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	500000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4800000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	100000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3000000.0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	27800000	USD
CY2020	us-gaap	Interest Expense InterestExpense	0	USD
CY2019	us-gaap	Interest Expense InterestExpense	0	USD
	us-gaap	Interest Expense InterestExpense	3700000	USD
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4900000	USD
CY2019	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5500000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6400000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	78100000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45700000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44700000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16400000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-25300000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	61700000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	36300000	USD
	us-gaap	Profit Loss ProfitLoss	70000000.0	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	900000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3300000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1200000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	60800000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	33000000.0	USD
	us-gaap	Net Income Loss NetIncomeLoss	68800000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.64
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48000000.0	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42000000.0	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41900000	shares
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.26
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.64
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48100000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42000000.0	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42000000.0	shares
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	605600000	USD
	us-gaap	Profit Loss ProfitLoss	70000000.0	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	300000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1400000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	674500000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	36300000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	100700000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1300000	USD
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	3900000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	808900000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	61700000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100000	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	300000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2000000.0	USD
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	600000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	871800000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	61700000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	36300000	USD
	us-gaap	Profit Loss ProfitLoss	70000000.0	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4900000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6700000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3900000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	23100000	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	9500000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-24800000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	700000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	500000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4800000	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	4900000	USD
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3500000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2000000.0	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1300000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	300000	USD
CY2020	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	900000	USD
CY2019	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	1300000	USD
	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	300000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	100000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3000000.0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	27800000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	100000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	100000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	900000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	281700000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	531700000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	361100000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3400000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-300000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1600000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	24000000.0	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	41900000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	18400000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3900000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	40500000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	37500000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	3100000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1200000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-2300000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	168400000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-391200000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-283000000.0	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	600000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	900000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	100000	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	4300000	USD
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	100000	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	800000	USD
CY2020	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	1300000	USD
CY2019	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	USD
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	258300000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5000000.0	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-800000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	259000000.0	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	100700000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	300000000.0	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	435000000.0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	200000	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	118900000	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	85000000.0	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	500000	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5300000	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6900000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2300000	USD
CY2019	us-gaap	Depreciation Depreciation	300000	USD
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	600000	USD
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	3900000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1400000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards	300000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards	100000	USD
	us-gaap	Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	174900000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	439800000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4000000.0	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11500000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	47800000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-28000000.0	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382800000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	335000000.0	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	363000000.0	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	394300000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382800000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	335000000.0	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	900000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-3100000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1700000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-3400000	USD
CY2020	us-gaap	Fiscal Period FiscalPeriod	<div style="text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Fiscal Year</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the merger with D.R. Horton, the Company changed its fiscal year-end from December 31 to September 30, effective January 1, 2018. This change aligned Forestar's fiscal year-end reporting calendar with D.R. Horton. The Company's results of operations, cash flows and all transactions impacting stockholders' equity presented in this Form 10-K are for the fiscal years ended September 30, 2020 and 2019 and for the nine months ended September 30, 2018 unless otherwise noted. This Form 10-K also includes an unaudited statement of operations for the comparable stub period of January 1, 2017 to September 30, 2017. See Note 17.</span></div>
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2700000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2900000	USD
CY2020	us-gaap	Depreciation Depreciation	300000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2300000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4300000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1200000	USD
CY2019Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1900000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1100000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2400000	USD
	us-gaap	Depreciation Depreciation	200000	USD
	us-gaap	Revenues Revenues	78300000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	49500000	USD
CY2020	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending Accounting Standards</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses,” which replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information in determining credit loss estimates. The guidance is effective for the Company beginning October 1, 2020 and is not expected to have a material impact on its consolidated financial position, results of operations or cash flows.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12 related to simplifying the accounting for income taxes. The guidance is effective for the Company beginning October 1, 2021, although early adoption is permitted. The Company is currently evaluating the impact of this guidance, and it is not expected to have a material impact on its consolidated financial position, results of operations or cash flows.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform,” which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by the discontinuation of the London Interbank Offered Rate (LIBOR) or by another reference rate expected to be discontinued. The guidance was effective beginning March 12, 2020 and can be applied prospectively through December 31, 2022. The Company will adopt this standard when LIBOR is discontinued and does not expect it to have a material impact on its consolidated financial statements and related disclosures.</span></div>
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19400000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4800000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	27800000	USD
	us-gaap	Interest Expense InterestExpense	3700000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6400000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44700000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1200000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	43500000	USD
CY2020Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1309700000	USD
CY2019Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1028900000	USD
CY2020	us-gaap	Payments To Acquire Residential Real Estate PaymentsToAcquireResidentialRealEstate	550800000	USD
CY2020	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	503000000.0	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	800000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	300000	USD
CY2020	for	Due Diligence Write Offs DueDiligenceWriteOffs	900000	USD
CY2019	for	Due Diligence Write Offs DueDiligenceWriteOffs	200000	USD
CY2020	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	400000	USD
CY2019	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	2300000	USD
	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	700000	USD
CY2020	us-gaap	Revenues Revenues	931800000	USD
CY2019	us-gaap	Revenues Revenues	428300000	USD
	us-gaap	Revenues Revenues	78300000	USD
CY2019Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	23700000	USD
CY2018Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	3200000	USD
CY2017Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	500000	USD
CY2020	us-gaap	Interest Costs Incurred InterestCostsIncurred	43300000	USD
CY2019	us-gaap	Interest Costs Incurred InterestCostsIncurred	25300000	USD
	us-gaap	Interest Costs Incurred InterestCostsIncurred	7300000	USD
CY2020	us-gaap	Interest Expense InterestExpense	0	USD
CY2019	us-gaap	Interest Expense InterestExpense	0	USD
	us-gaap	Interest Expense InterestExpense	3700000	USD
CY2020	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	18300000	USD
CY2019	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	4800000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	900000	USD
CY2020Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	48700000	USD
CY2019Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	23700000	USD
CY2018Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	3200000	USD
CY2020Q3	for	Numberof Equity Method Investments NumberofEquityMethodInvestments	4	venture
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	3600000	USD
CY2019Q3	us-gaap	Equity Method Investments EquityMethodInvestments	7300000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	700000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	500000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4800000	USD
CY2020Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	400000	USD
CY2019Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	1100000	USD
CY2020Q3	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	4800000	USD
CY2019Q3	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	0	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3600000	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2020Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	4900000	USD
CY2019Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	3400000	USD
CY2020Q3	us-gaap	Deposits Assets DepositsAssets	5500000	USD
CY2019Q3	us-gaap	Deposits Assets DepositsAssets	5100000	USD
CY2020Q3	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	5700000	USD
CY2019Q3	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	4100000	USD
CY2020Q3	us-gaap	Other Assets OtherAssets	24900000	USD
CY2019Q3	us-gaap	Other Assets OtherAssets	13700000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	6200000	USD
CY2019Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	5600000	USD
CY2020Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	3800000	USD
CY2019Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	2100000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3800000	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	USD
CY2020Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	14000000.0	USD
CY2019Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	13500000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	200000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2500000	USD
CY2020Q3	us-gaap	Deferred Revenue DeferredRevenue	9300000	USD
CY2019Q3	us-gaap	Deferred Revenue DeferredRevenue	9300000	USD
CY2020Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	500000	USD
CY2019Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	0	USD
CY2020Q3	for	Accrued Development Costs AccruedDevelopmentCosts	35300000	USD
CY2019Q3	for	Accrued Development Costs AccruedDevelopmentCosts	35400000	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	10200000	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	8400000	USD
CY2020Q3	us-gaap	Other Liabilities OtherLiabilities	10500000	USD
CY2019Q3	us-gaap	Other Liabilities OtherLiabilities	2800000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	93800000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	79600000	USD
CY2020Q3	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2019Q3	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	641100000	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	460500000	USD
CY2020Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	380000000	USD
CY2020Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	570000000	USD
CY2020Q3	for	Letterof Credit Maximum Borrowing Capacity LetterofCreditMaximumBorrowingCapacity	100000000	USD
CY2020Q3	for	Letterof Credit Maximum Borrowing Capacity Percentageof Revolving Credit Commitment LetterofCreditMaximumBorrowingCapacityPercentageofRevolvingCreditCommitment	0.50
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2020Q3	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2020Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	36000000.0	USD
CY2020Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	344000000.0	USD
CY2020Q2	for	Debt Repurchase Program Authorized Amount DebtRepurchaseProgramAuthorizedAmount	30000000	USD
CY2020Q3	for	Debt Repurchase Program Authorized Amount DebtRepurchaseProgramAuthorizedAmount	30000000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	394300000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	382800000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	60800000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	33000000.0	USD
	us-gaap	Net Income Loss NetIncomeLoss	68800000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48037018	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41974429	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41938987	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	57093	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	30712	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	30069	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48094111	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42005141	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41969056	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.64
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.26
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.64
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-7600000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-300000	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-500000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	900000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	300000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-6700000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-500000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	21200000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	9100000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.03
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-23500000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1900000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	300000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1300000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23100000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9400000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-24800000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16400000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-25300000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.81
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.02
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.01
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.01
	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.01
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.57
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2300000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	10500000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	10200000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	1500000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	1500000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1700000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15100000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	0	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	600000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	200000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	200000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13900000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	27600000	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	200960	shares
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1500000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3300000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	12400000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	24300000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	18100000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	6400000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	500000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	18100000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6900000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	5700000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	17400000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1500000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3300000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1100000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1600000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	USD
	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	500000	USD
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1600000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1600000	USD
	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	USD
CY2020Q3	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	USD
CY2018Q3	for	Equity Securities Registered Value EquitySecuritiesRegisteredValue	500000000	USD
CY2020Q3	for	Common Stock Availablefor Issuance Value Remaining CommonStockAvailableforIssuanceValueRemaining	394300000	USD
CY2020Q3	for	At The Market Equity Offering Program Common Stock Available For Issuance AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance	100000000	USD
CY2020Q3	for	At The Market Equity Offering Program Common Stock Available For Issuance AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance	100000000	USD
CY2020Q3	for	At The Market Equity Offering Program Common Stock Issued AtTheMarketEquityOfferingProgramCommonStockIssued	0	shares
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	400000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000	USD
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.68
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	86500	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	18.09
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	85994	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	17.54
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	181325	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.11
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	149400	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	20.24
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	12000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.35
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	79432	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	19.58
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	23740	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	18.03
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	500	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	18.40
CY2020	for	Numberof Lots Sold NumberofLotsSold	10373	Lot
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	16990	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	19.10
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	11200	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	18.39
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	10994	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	18.40
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	285863	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	17.47
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	200960	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.68
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	86500	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	18.09
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1600000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	400000	USD
CY2020Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	3200000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M6D
CY2020Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	36000000.0	USD
CY2020Q3	us-gaap	Special Assessment Bond SpecialAssessmentBond	236900000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1100000	USD
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	600000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1200000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	900000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	900000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	700000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	300000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0.0	USD
CY2020Q3	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	60500	Lot
CY2019Q3	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	38300	Lot
CY2019Q4	us-gaap	Profit Loss ProfitLoss	16800000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	10400000	USD
CY2019	for	Numberof Lots Sold NumberofLotsSold	4132	Lot
	for	Numberof Lots Sold NumberofLotsSold	1024	Lot
CY2020Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	8400000	USD
CY2019Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2200000	USD
CY2019Q4	us-gaap	Revenues Revenues	247200000	USD
CY2020Q1	us-gaap	Revenues Revenues	159100000	USD
CY2020Q2	us-gaap	Revenues Revenues	177900000	USD
CY2020Q3	us-gaap	Revenues Revenues	347600000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	22200000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13700000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10300000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	32000000.0	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5400000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3300000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7500000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	10100000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	24500000	USD
CY2019Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	800000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	16900000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	9600000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	10100000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	24200000	USD
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.50
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.50
CY2018Q4	us-gaap	Revenues Revenues	38500000	USD
CY2019Q1	us-gaap	Revenues Revenues	65300000	USD
CY2019Q2	us-gaap	Revenues Revenues	88200000	USD
CY2019Q3	us-gaap	Revenues Revenues	236300000	USD
CY2018Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4900000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16400000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8400000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16000000.0	USD
CY2018Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000000.0	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3600000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1500000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3400000	USD
CY2018Q4	us-gaap	Profit Loss ProfitLoss	3900000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	12800000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	6900000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	12600000	USD
CY2018Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	600000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2700000	USD
CY2019Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	3300000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	10100000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	6900000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	12700000	USD
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
	us-gaap	Revenues Revenues	78300000	USD
	us-gaap	Revenues Revenues	83500000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	49500000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	90100000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19400000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	51200000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4800000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	10900000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	27800000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	113400000	USD
	us-gaap	Interest Expense InterestExpense	3700000	USD
	us-gaap	Interest Expense InterestExpense	6400000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6400000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2400000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44700000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	62500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-25300000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33400000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	70000000.0	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	29100000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	38800000	USD
	us-gaap	Profit Loss ProfitLoss	70000000.0	USD
	us-gaap	Profit Loss ProfitLoss	67900000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1200000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	100000	USD
	us-gaap	Net Income Loss NetIncomeLoss	68800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	67800000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41900000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42200000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42000000.0	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42500000	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.64
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.69
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.92
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.64
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.61
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.64
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.68
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.59

Files In Submission

Name	View Source	Status
0001406587-20-000087-index-headers.html	Edgar Link	pending
0001406587-20-000087-index.html	Edgar Link	pending
0001406587-20-000087.txt	Edgar Link	pending
0001406587-20-000087-xbrl.zip	Edgar Link	pending
a9302020ex211subsidiar.htm	Edgar Link	pending
a9302020ex231auditcons.htm	Edgar Link	pending
a9302020exhibit107.htm	Edgar Link	pending
a9302020exhibit311.htm	Edgar Link	pending
a9302020exhibit312.htm	Edgar Link	pending
a9302020exhibit321.htm	Edgar Link	pending
a9302020exhibit322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
for-20200930.htm	Edgar Link	pending
for-20200930.xsd	Edgar Link	pending
for-20200930_cal.xml	Edgar Link	unprocessable
for-20200930_def.xml	Edgar Link	unprocessable
for-20200930_g1.jpg	Edgar Link	pending
for-20200930_htm.xml	Edgar Link	completed
for-20200930_lab.xml	Edgar Link	unprocessable
for-20200930_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOR
Forestar Group Inc. Stock $for

2020 Form 10-K Financial Statement

#000140658720000087 Filed on November 19, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOR Forestar Group Inc. Stock $for

2020 Form 10-K Financial Statement

#000140658720000087 Filed on November 19, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOR
Forestar Group Inc. Stock $for